Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas.
Saved in:
| Title: | Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas. |
|---|---|
| Authors: | Schaefer IM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Lundberg MZ; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Demicco EG; Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Przybyl J; Department of Pathology, Stanford University School of Medicine, Stanford, California., Matusiak M; Department of Pathology, Stanford University School of Medicine, Stanford, California., Chibon F; The Institut national de la santé et de la recherche médicale (INSERM) U1037, Cancer Research Center of Toulouse, Department of Pathology, Claudius Régaud Institute, IUCT-Oncopole, Toulouse, France., Ingram DR; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hornick JL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bauer S; Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University Duisburg-Essen Medical School, Essen, Germany.; Partner Site Essen and German Cancer Consortium, Heidelberg, Germany., Baker LH; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., van de Rijn M; Department of Pathology, Stanford University School of Medicine, Stanford, California., Mariño-Enríquez A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Fletcher JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. |
| Source: | Cancer [Cancer] 2021 Aug 01; Vol. 127 (15), pp. 2666-2673. Date of Electronic Publication: 2021 Mar 31. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
